Why Maravai Lifesciences Holdings Inc (MRVI) Stock is Currently -33.47% Off from Its 20-Day SMA?
William Blair has recently reduced Maravai Lifesciences Holdings Inc (MRVI) stock to Mkt Perform rating, as announced on November 8, 2024, according to Finviz. Earlier, on August 28, 2024, Wells Fargo had initiated the stock to Overweight, setting a price target of $10. Morgan Stanley also reduced rating with a price target of $10. Additionally, […]
What’s Causing Maravai Lifesciences Holdings Inc (MRVI) Stock’s -16.83% Drop Over the Last Six Months?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of $15. […]
Maravai Lifesciences Holdings Inc (MRVI) Stock Sees Market Value Hit $1.92 billion: What Are the Implications?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Maravai Lifesciences Holdings Inc (MRVI) Reported a -13.85% Operating Margin Last Year—What’s the Real Story?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Uncover the Reason: Why Maravai Lifesciences Holdings Inc (MRVI) Stock Is Trading 57.74% Above Its 52-Week Low?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Maravai Lifesciences Holdings Inc (MRVI) Stock: Unveiling Its Hidden Strengths
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
The Maravai Lifesciences Holdings Inc Stock Thriller: Decoding the Mystery Behind MRVI’s Recent Movements
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Why Is Maravai Lifesciences Holdings Inc (MRVI) Stock Lagging Behind -3.74% from Its 50-Day SMA?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Why Did Maravai Lifesciences Holdings Inc (MRVI) Stock Plunge -4.60% Last Week?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]
Maravai Lifesciences Holdings Inc (MRVI) Stock: Beyond the Surface of Its Performance?
Wells Fargo has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on August 13, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $10 for MRVI stock. Craig Hallum also initiated Buy rating with a price target of […]